These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 22869678

  • 41. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA.
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [Abstract] [Full Text] [Related]

  • 42. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 43. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
    Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.
    Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
    [Abstract] [Full Text] [Related]

  • 44. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.
    Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.
    Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838
    [Abstract] [Full Text] [Related]

  • 45. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L, Saumu MT, Wang H, Shi H, Hu X, Cheng P.
    J Huazhong Univ Sci Technolog Med Sci; 2005 Apr; 25(3):348-50, 370. PubMed ID: 16201293
    [Abstract] [Full Text] [Related]

  • 46. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
    Yang X, Liu G, Huang Y, Chen S, Du J, Jin H.
    Cardiol Young; 2015 Aug; 25(6):1182-90. PubMed ID: 25597708
    [Abstract] [Full Text] [Related]

  • 47. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
    Pediatrics; 2012 Jan; 129(1):e17-23. PubMed ID: 22144699
    [Abstract] [Full Text] [Related]

  • 48. Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease: An Analysis of Post RAISE.
    Miyata K, Miura M, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H.
    Circ Cardiovasc Qual Outcomes; 2021 Feb; 14(2):e007191. PubMed ID: 33541111
    [Abstract] [Full Text] [Related]

  • 49. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG, Gauvreau K, Baker A, Son MB, Sundel R, Dionne A, Giorgio T, De Ferranti S, Newburger JW.
    Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
    [Abstract] [Full Text] [Related]

  • 50. Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease.
    Nagakura A, Morikawa Y, Sakakibara H, Miura M.
    J Pediatr; 2017 Jun; 185():106-111.e1. PubMed ID: 28343657
    [Abstract] [Full Text] [Related]

  • 51. [Anti TNF-α (infliximab) treatment for intravenous immunoglobulin (IVIG) resistance patients with acute Kawasaki disease the effects of anticytokine therapy].
    Saji T, Takatsuki S, Kobayashi T.
    Nihon Rinsho; 2014 Sep; 72(9):1641-9. PubMed ID: 25518416
    [Abstract] [Full Text] [Related]

  • 52. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 53. Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.
    Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S.
    Int J Mol Sci; 2016 Feb 24; 17(3):278. PubMed ID: 26927060
    [Abstract] [Full Text] [Related]

  • 54. Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
    Jibiki T, Kato I, Shiohama T, Abe K, Anzai S, Takeda N, Yamaguchi KI, Kanazawa M, Kurosaki T.
    Pediatr Int; 2011 Oct 24; 53(5):729-735. PubMed ID: 21342358
    [Abstract] [Full Text] [Related]

  • 55. Patterns of Fever in Children After Primary Treatment for Kawasaki Disease.
    Jaggi P, Wang W, Dvorchik I, Printz B, Berry E, Kovalchin JP, Texter K, Ramilo O, Burns JC, Tremoulet AH.
    Pediatr Infect Dis J; 2015 Dec 24; 34(12):1315-8. PubMed ID: 26353031
    [Abstract] [Full Text] [Related]

  • 56. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J, Wang B, Zeng Y, Xu H.
    Eur J Dermatol; 2010 Dec 24; 20(6):743-7. PubMed ID: 20952352
    [Abstract] [Full Text] [Related]

  • 57. [Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].
    Kobayashi T, Inoue Y, Morikawa A.
    Nihon Rinsho; 2008 Feb 24; 66(2):332-7. PubMed ID: 18260333
    [Abstract] [Full Text] [Related]

  • 58. What dose of aspirin should be used in the initial treatment of Kawasaki disease? A meta-analysis.
    Jia X, Du X, Bie S, Li X, Bao Y, Jiang M.
    Rheumatology (Oxford); 2020 Aug 01; 59(8):1826-1833. PubMed ID: 32159800
    [Abstract] [Full Text] [Related]

  • 59. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.
    Sundel RP, Baker AL, Fulton DR, Newburger JW.
    J Pediatr; 2003 Jun 01; 142(6):611-6. PubMed ID: 12838187
    [Abstract] [Full Text] [Related]

  • 60. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
    Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y.
    Int Arch Allergy Immunol; 2014 Jun 01; 164(2):83-8. PubMed ID: 24903098
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.